Renin-angiotensin system-related gene polymorphisms are associated with risk of atrial fibrillation

American Heart Journal

Volumn 160, Issue 3, 2010, Pages 496-505

  Xiao, Peilin ^a   Ling, Zhiyu ^a   Woo, Kamsang ^b   Du, Huaan ^a   Su, Li ^a   Liu, Zengzhang ^a   Yin, Yuehui ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; ETHNICITY; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; META ANALYSIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMATIC REVIEW; GENETICS; GENOTYPE; PHYSIOLOGY;

ATRIAL FIBRILLATION; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 77956358732     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.06.013     Document Type: Article

References (32)

1. Go A.S., Hylek E.M., and Phillips K.A. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375
2. Benjamin E.J., Wolf P.A., and D'Agostino R.B. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
3. Goette A., Staack T., and Rocken C. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation J Am Coll Cardiol 35 2000 1669 1677
4. Madrid A.H., Bueno M.G., and Rebollo J.M.G. Use of Irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation Circulation 106 2002 331 336
5. Yin Y., Dalal D., and Liu Z. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation Eur Heart J 27 2006 1841 1846
6. Samani N.J., Thompson J.R., and O'Toole L. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction Circulation 94 1996 708 712
7. Cambien F., Alhenc-Gelas F., and Herbeth B. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study Am J Hum Genet 43 1988 774 780
8. Rigat B., Hubert C., and Corvol P. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1) Nucleic Acids Res 20 1992 1433
9. Rigat B., Hubert C., and Alhenc-Gelas F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J Clin Invest 86 1990 1343 1346
10. Xu M.Q., Ye Z., and Hu F.B. Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease Circulation 116 2007 1356 1366
11. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation JACC 48 2006 149 246
12. Lindley D. Statistical inference concerning Hardy-Weinberg equilibrium Bayesian Stat 3 1988 307 326
13. Robins J., Greenland S., and Breslow N.E. A general estimator for the variance of the Mantel-Haenszel odds ratio Am J Epidemiol 124 1986 719 723
14. Mantel N., and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
15. Fleiss J.L. Measure of effect size for categorical data H. Cooper, L.V. Hedges, The handbook of research synthesis 1994 Russell Sage Foundation New York, NY 245 260
16. Higgins J.P., Thompson S.G., and Deeks J.J. Measuring inconsistency in meta-analyses Br Med J 327 2003 557 560
17. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
18. Egger M., Davey Smith G., and Schneider M. Bias in meta-analysis detected by a simple, graphical test Br Med J 315 1997 629 634
19. Asselbergs F.W., Moore J.H., and van den Berg M.P. A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study BMC Med Genet 7 2006 39
20. Gensini F., Padeletti L., and Fatini C. Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation Pacing Clin Electrophysiol 26 2003 295 298
21. Tziakas D.N., Chalikias G.K., and Stakos D.A. Effect of angiotensin-converting enzyme insertion/deletion genotype on collagen type I synthesis and degradation in patients with atrial fibrillation and arterial hypertension Expert Opin Pharmacother 8 2007 2225 2234
22. Huang M., Gai X., and Yang X. Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease Clin Chem Lab Med 47 2009 32 37
23. Bedi M., McNamara D., and London B. Genetic susceptibility to atrial fibrillation in patients with congestive heart failure Heart Rhythm 3 2006 808 812
24. Yamashita T., Hayami N., and Ajiki K. Is ACE gene polymorphism associated with lone atrial fibrillation? Jpn Heart J 38 1997 637 641
25. Fatini C., Sticchi E., and Gensini F. Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility Intern Cardiol 120 2007 59 65
26. Tsai C.T., Lai L.P., and Lin J.L. Renin-angiotensin system gene polymorphisms and atrial fibrillation Circulation 109 2004 1640 1646
27. Wei L., Wei W.T., and Lu G.L. The association of polymorphisms in the angiotensin-converting enzyme insertion/deletion gene with nonvulvular atrial fibrillation Chin Cardiac Pacing and Electrophysiol 22 2008 333 336
28. Wang S.M., Zhang P., and Chen F.R. Study the association between ACE gene polymorphism Chin Intern Med 23 2003 537 538
29. Chang H.Y., Yang S.S., and Han W. Associations of the polymorphisms in renin-angiotensin system with nonfamilial structural atrial fibrillation Hei Long Jing Med 31 2007 731 733
30. Ravn L.S., Benn M., and Nordestgaard B.G. Nordestgaard, angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population Pharmacogenet Genomics 18 2008 525 533
31. Ogimoto A., Higaki J., and Miki T. Polymorphism of inhibitory renin-angiotensin system as a genetic risk factor for atrial fibrillation Circulation e329 2004 110
32. Darbar D., Motsinger A.A., and Ritchie M.D. Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation Heart Rhythm 4 2007 743 749